Abstract
Uterine fibroids are one of the most common benign uterine tumors seen in females of reproductive age group. They either may be completely asymptomatic (diagnosed incidentally while doing ultrasound for some other reason) or may present as menorrhagia, lower abdominal or back pain, pelvic mass, obstructive uropathy, anemia secondary to blood loss and infertility. The management of uterine fibroids depends upon factors like possibility of pregnancy in future, whether preservation of uterus is desirable, severity and characteristics of symptoms. Various treatment options include observation and follow up, medical management (Mifepristone or Ulipristal acetate), uterine fibroid embolisation and hysterectomy. This study was done to know the effect of ulipristal acetate and mifepristone on Menstrual blood Loss, Dysmenorrhea, Uterine size & fibroid size. This was a comparative study done in 160 patients attending outpatient department of Obstetrics and Gynaecology of Patna Medical College and Hospital (PMCH). Treatment of symptomatic fibroids by Mifepristone as well as Ulipristal acetate was associated with reduction in fibroid size, reduced blood loss and decreased pain. We conclude from this study that both these drugs can be used for treatment of symptomatic fibroids
 Keywords: Uterine Fibroid, Ulipristal Acetate, Mifepristone
Highlights
A Uterine fibroid is the most common type of benign tumor of uterus and the most common pelvic tumor in women
Uterine fibroids are one of the most common benign uterine tumors seen in females of reproductive age group
This study was done to know the effect of ulipristal acetate and mifepristone on Menstrual blood Loss, Dysmenorrhea, Uterine size & fibroid size
Summary
A Uterine fibroid is the most common type of benign tumor of uterus and the most common pelvic tumor in women. Uterine fibroid ( called uterine leiomyoma, myoma, fibromyoma, fibroleiomyoma & fibroma) is non-cancerous benign tumour that originates from the smooth muscle layer and the accompanying connective tissue of uterus. It occurs one in every four or five women of reproductive age, typically reported in 20-40% of reproductive age group women. The risk factors for developing fibroids include obesity, nulliparity, younger age at menarche and African race. [4] The diagnosis of uterine fibroids is usually done by ultrasound
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical and Biomedical Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
